These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 21821631)

  • 21. Fourier transform infrared imaging spectroscopy (FT-IRIS) of mineralization in bisphosphonate-treated oim/oim mice.
    Camacho NP; Carroll P; Raggio CL
    Calcif Tissue Int; 2003 May; 72(5):604-9. PubMed ID: 12574874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of bisphosphonates on matrix mineralization.
    Boivin G; Meunier PJ
    J Musculoskelet Neuronal Interact; 2002 Dec; 2(6):538-43. PubMed ID: 15758388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical results of alendronate monotherapy and combined therapy with menatetrenone (VitK₂) in postmenopausal RA patients.
    Suzuki K; Tsuji S; Fukushima Y; Nakase T; Hamada M; Tomita T; Yoshikawa H
    Mod Rheumatol; 2013 May; 23(3):450-5. PubMed ID: 22692649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone Mineral and Organic Properties in Postmenopausal Women Treated With Denosumab for Up to 10 years.
    Farlay D; Rizzo S; Dempster DW; Huang S; Chines A; Brown JP; Boivin G
    J Bone Miner Res; 2022 May; 37(5):856-864. PubMed ID: 35249242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term risedronate treatment normalizes mineralization and continues to preserve trabecular architecture: sequential triple biopsy studies with micro-computed tomography.
    Borah B; Dufresne TE; Ritman EL; Jorgensen SM; Liu S; Chmielewski PA; Phipps RJ; Zhou X; Sibonga JD; Turner RT
    Bone; 2006 Aug; 39(2):345-52. PubMed ID: 16571382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Osteoporosis and thyrotropin-suppressive therapy: reduced effectiveness of alendronate.
    Panico A; Lupoli GA; Fonderico F; Marciello F; Martinelli A; Assante R; Lupoli G
    Thyroid; 2009 May; 19(5):437-42. PubMed ID: 19415993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alendronate and indapamide alone or in combination in the management of hypercalciuria associated with osteoporosis: a randomized controlled trial of two drugs and three treatments.
    Giusti A; Barone A; Pioli G; Girasole G; Siccardi V; Palummeri E; Bianchi G
    Nephrol Dial Transplant; 2009 May; 24(5):1472-7. PubMed ID: 19075192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Upper gastrointestinal tolerability of alendronate sodium monohydrate 10 mg once daily in postmenopausal women: a 12-week, randomized, double-blind, placebo-controlled, exploratory study.
    Adachi JD; Faraawi RY; O'Mahony MF; Nayar A; Massaad R; Evans JK; Yacik C
    Clin Ther; 2009 Aug; 31(8):1747-53. PubMed ID: 19808133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of 3- and 5-year treatment with risedronate on bone mineralization density distribution in triple biopsies of the iliac crest in postmenopausal women.
    Zoehrer R; Roschger P; Paschalis EP; Hofstaetter JG; Durchschlag E; Fratzl P; Phipps R; Klaushofer K
    J Bone Miner Res; 2006 Jul; 21(7):1106-12. PubMed ID: 16813531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Respective roles of organic and mineral components of human cortical bone matrix in micromechanical behavior: an instrumented indentation study.
    Bala Y; Depalle B; Douillard T; Meille S; Clément P; Follet H; Chevalier J; Boivin G
    J Mech Behav Biomed Mater; 2011 Oct; 4(7):1473-82. PubMed ID: 21783157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distribution of strontium and mineralization in iliac bone biopsies from osteoporotic women treated long-term with strontium ranelate.
    Doublier A; Farlay D; Khebbab MT; Jaurand X; Meunier PJ; Boivin G
    Eur J Endocrinol; 2011 Sep; 165(3):469-76. PubMed ID: 21690207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of teriparatide on cortical histomorphometric variables in postmenopausal women with or without prior alendronate treatment.
    Ma YL; Zeng QQ; Chiang AY; Burr D; Li J; Dobnig H; Fahrleitner-Pammer A; Michalská D; Marin F; Pavo I; Stepan JJ
    Bone; 2014 Feb; 59():139-47. PubMed ID: 24269280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low bone mineral density is associated with bone microdamage accumulation in postmenopausal women with osteoporosis.
    Stepan JJ; Burr DB; Pavo I; Sipos A; Michalska D; Li J; Fahrleitner-Pammer A; Petto H; Westmore M; Michalsky D; Sato M; Dobnig H
    Bone; 2007 Sep; 41(3):378-85. PubMed ID: 17597017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative effects of raloxifene and alendronate on fracture outcomes in postmenopausal women with low bone mass.
    Recker RR; Kendler D; Recknor CP; Rooney TW; Lewiecki EM; Utian WH; Cauley JA; Lorraine J; Qu Y; Kulkarni PM; Gaich CL; Wong M; Plouffe L; Stock JL
    Bone; 2007 Apr; 40(4):843-51. PubMed ID: 17182297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of teriparatide and alendronate on vertebral strength as assessed by finite element modeling of QCT scans in women with osteoporosis.
    Keaveny TM; Donley DW; Hoffmann PF; Mitlak BH; Glass EV; San Martin JA
    J Bone Miner Res; 2007 Jan; 22(1):149-57. PubMed ID: 17042738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral ibandronate in postmenopausal osteoporotic women alters micromechanical properties independently of changes in mineralization.
    Bala Y; Kohles J; Recker RR; Boivin G
    Calcif Tissue Int; 2013 Jan; 92(1):6-14. PubMed ID: 23090678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Marked reduction of bone turnover by alendronate attenuates the acute response of bone resorption marker to endogenous parathyroid hormone.
    Zikan V; Stepan JJ
    Bone; 2009 Apr; 44(4):634-8. PubMed ID: 19150421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential effects of teriparatide and alendronate on bone remodeling in postmenopausal women assessed by histomorphometric parameters.
    Arlot M; Meunier PJ; Boivin G; Haddock L; Tamayo J; Correa-Rotter R; Jasqui S; Donley DW; Dalsky GP; Martin JS; Eriksen EF
    J Bone Miner Res; 2005 Jul; 20(7):1244-53. PubMed ID: 15940379
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone matrix quality in paired iliac bone biopsies from postmenopausal women treated for 12 months with strontium ranelate or alendronate.
    Falgayrac G; Farlay D; Ponçon C; Béhal H; Gardegaront M; Ammann P; Boivin G; Cortet B
    Bone; 2021 Dec; 153():116107. PubMed ID: 34260980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis.
    Chavassieux PM; Arlot ME; Reda C; Wei L; Yates AJ; Meunier PJ
    J Clin Invest; 1997 Sep; 100(6):1475-80. PubMed ID: 9294113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.